OTC · Healthcare

C21 Investments Inc. (CXXIF)

As-reported financials and recent SEC filings for C21 Investments Inc., latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$32.6M

Net income

$-3.2M

Net margin

-9.9%

Diluted EPS

$-0.03

ROE

-12.8%

P/E (TTM)

—

Market cap

—

Debt / equity

—

Income statement (as reported)

Line	FY2026	FY2025	FY2024	FY2023	FY2022
Revenue	$32.6M	$30.1M	$28.3M	$28.9M	$33.0M
Gross profit	$13.6M	$12.6M	$11.1M	$13.4M	$18.8M
Operating income	$2.3M	$1.3M	$1.5M	$4.0M	$9.8M
Net income	$-3.2M	$-4.0M	$-3.3M	$293,211	$10.0M
Diluted EPS	$-0.03	$-0.03	$-0.03	$0.00	$0.08

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

6-K2026-06-22

6-K2026-06-15

20-F2026-06-12

6-K2026-06-12

S-82026-03-19

6-K2026-02-10

6-K2026-02-10

6-K2025-11-12

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on CXXIF

Search C21 Investments Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.